EnviroGold Global Announces Positive Initial Test Results with a Second Major Global Metal Production Company
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global” […]
Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Refined Metals Corp. (CSE: RMC; OTC: RFMCF; FRA: CWA0) (the “Company”) […]
ATHA Energy Announces Appointment of Ryan Gaffney as Senior Vice President, Business Development
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or […]
Draganfly Announces Closing of US$3.6 Million Underwritten Public Offering
Saskatoon, SK., Feb. 26, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER […]
Canadian GoldCamps Enters into LOI to Acquire up to 70% interest in Murphy Lake Property located in the Athabasca Basin, Saskatchewan
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Canadian GoldCamps Corp. (“Canadian GoldCamps”, or the “Company”) (CSE: CAMP) (FSE: A68) is […]
Platinex Inc. Announces Name Change to PTX Metals Inc.
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased […]
HydroGraph Announces Closing of Second Tranche of Private Placement
Not for distribution to U.S. newswire services or dissemination in the United States VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE […]
United Lithium Announces the Commencement of OTCQX Trading
VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) — United Lithium Corp. (“United” or the “Company”) (CSE: ULTH; OTCQX: ULTHF; […]
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
For the first time, patients with alcohol use disorder will receive the company’s unique and proprietary psychedelic – MEAI Vancouver, […]
